Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia

LJ Dominguez, N Veronese, L Vernuccio, G Catanese… - Nutrients, 2021 - mdpi.com
Multiple factors combined are currently recognized as contributors to cognitive decline. The
main independent risk factor for cognitive impairment and dementia is advanced age …

[HTML][HTML] Mechanistic insights and perspectives involved in neuroprotective action of quercetin

AK Grewal, TG Singh, D Sharma, V Sharma… - Biomedicine & …, 2021 - Elsevier
Neurodegenerative diseases (NDDs) are the primary cause of disabilities in the elderly
people. Growing evidence indicates that oxidative stress, mitochondrial dysfunction …

Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics

L Cassidy, F Fernandez, JB Johnson, M Naiker… - … therapies in medicine, 2020 - Elsevier
Objectives The aim of this research was to review the literature on Alzheimer's disease (AD)
with a focus on polyphenolics as antioxidant therapeutics. Design This review included a …

Neuropharmacological effects of quercetin: a literature-based review

MS Islam, C Quispe, R Hossain, MT Islam… - Frontiers in …, 2021 - frontiersin.org
Quercetin (QUR) is a natural bioactive flavonoid that has been lately very studied for its
beneficial properties in many pathologies. Its neuroprotective effects have been …

Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions

N Suganthy, KP Devi, SF Nabavi, N Braidy… - Biomedicine & …, 2016 - Elsevier
Quercetin, a ubiquitous flavonoid that is widely distributed in plants is classified as a
cognitive enhancer in traditional and oriental medicine. The protective effects of quercetin for …

C1q: A fresh look upon an old molecule

NM Thielens, F Tedesco, SS Bohlson, C Gaboriaud… - Molecular …, 2017 - Elsevier
Originally discovered as part of C1, the initiation component of the classical complement
pathway, it is now appreciated that C1q regulates a variety of cellular processes …

[HTML][HTML] An update on the novel and approved drugs for Alzheimer disease

HA Alhazmi, M Albratty - Saudi Pharmaceutical Journal, 2022 - Elsevier
Introduction Given the severity of the condition and the increasing number of patients,
developing effective therapies for Alzheimer's disease has become a significant necessity …

Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer's disease: A neuropharmacological review of their bioactive constituents

N Gorji, R Moeini, Z Memariani - Pharmacological Research, 2018 - Elsevier
An increase in the prevalence of Alzheimer's disease (AD) as a multifactorial
neurodegenerative disorder is an almost obvious issue in the world. Researches on natural …

Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active Ingredients

C Ude, M Schubert-Zsilavecz, M Wurglics - Clinical pharmacokinetics, 2013 - Springer
Ginkgo biloba is among the most favourite and best explored herbal drugs. Standardized
extracts of Ginkgo biloba represent the only herbal alternative to synthetic antidementia …

Protein folding and aggregation into amyloid: the interference by natural phenolic compounds

M Stefani, S Rigacci - International journal of molecular sciences, 2013 - mdpi.com
Amyloid aggregation is a hallmark of several degenerative diseases affecting the brain or
peripheral tissues, whose intermediates (oligomers, protofibrils) and final mature fibrils …